We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Latest updates on SARS-CoV-2 variants detected in the UK.
Following a review of the effectiveness of current measures to reduce the risk of potentially long-term or irreversible side effects associated with fluoroquinolone antibiotics, the MHRA has introduced further restrictions to limit their use.
Thirty-day all-cause case fatality rates following healthcare associated infections (HCAI); MRSA, MSSA and Gram-negative bacteraemia (Escherichia coli (E. coli), Pseudomonas aeruginosa, Klebsiella spp.), and Clostridioides difficile (C. difficile) infection. Experimental statistics annual report and data tables, data up to March...
First published during the 2019 to 2022 Johnson Conservative government
The documentation accompanying an application for a marketing authorisation pursuant to Schedule 1 of the Veterinary Medicines Regulations shall be presented in accordance with the requirements set out in this Annex.
Employment Tribunal decision.
Mandatory Surveillance of Clostridioides difficile infection: July 2022 to July 2023
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).